Product Recalls in South Dakota

Product recalls affecting South Dakota — including food, drugs, consumer products, medical devices, and vehicles distributed to South Dakota. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,528 recalls have been distributed to South Dakota in the last 12 months.

47,632 total recalls
2,528 in last 12 months

Showing 60416060 of 13,354 recalls

DrugJanuary 28, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Bimatoprost Ophthalmic Solution 0.03% Recalled by Lupin Pharmaceuticals Inc....

The Issue: Failed Impurities/Degradation Specifications: OOS results observed in any...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 25, 2019· Akorn Inc

Recalled Item: Clobetasol Propionate Emollient Cream 0.05% Recalled by Akorn Inc Due to...

The Issue: Failed Stability Specification; out of specification (OOS) results for a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 24, 2019· Sun Pharmaceutical Industries, Inc.

Recalled Item: BromSite (bromfenac ophthalmic solution) 0.075% Recalled by Sun...

The Issue: Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 24, 2019· US Compounding Inc

Recalled Item: LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%)...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Prinston Pharmaceutical Inc

Recalled Item: Irbesartan and Hydrochlorothiazide Tablets Recalled by Prinston...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Prinston Pharmaceutical Inc

Recalled Item: Irbesartan and Hydrochlorothiazide Tablets Recalled by Prinston...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Prinston Pharmaceutical Inc

Recalled Item: Irbesartan and Hydrochlorothiazide Tablets Recalled by Prinston...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Prinston Pharmaceutical Inc

Recalled Item: Irbesartan Tablets 300 mg 90 count Rx only Manufactured by: Recalled by...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Prinston Pharmaceutical Inc

Recalled Item: Irbesartan and HydrochlorothiazideTablets Recalled by Prinston...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Mylan Pharmaceuticals Inc.

Recalled Item: Fexofenadine HCl Tablets Recalled by Mylan Pharmaceuticals Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications: Related compound results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Alprazolam Tablets Recalled by Mylan Institutional, Inc. (d.b.a. UDL...

The Issue: Failed Impurities/Degradation Specifications: Elevated levels of a known...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2019· KRS Global Biotechnology, Inc

Recalled Item: NORepinephrine 16 mg added to 0.9% Sodium Chloride (PF) Recalled by KRS...

The Issue: Labeling: Label mix-up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2019· KRS Global Biotechnology, Inc

Recalled Item: NORepinephrine 4 mg added to 5% Dextrose 250 mL Bag (PF) Recalled by KRS...

The Issue: Labeling: Label mix-up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2019· LUPIN SOMERSET

Recalled Item: Fluocinolone Acetonide Topical Solution Recalled by LUPIN SOMERSET Due to...

The Issue: Failed Impurities/Degradation Specifications: Expansion of October 2018...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ezetimibe and Simvastatin Tablets 10mg/80 mg Recalled by Dr. Reddy's...

The Issue: Presence of Foreign Substance: Product complaint of black speckles observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2019· Tris Pharma Inc.

Recalled Item: Infants' Ibuprofen Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2019· Tris Pharma Inc.

Recalled Item: Infants' Ibuprofen Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2019· Tris Pharma Inc.

Recalled Item: infants* IBUPROFEN Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 10, 2019· McGuff Compounding Pharmacy Services, Inc.

Recalled Item: Lipoic Acid Injection (aka Alpha Lipoic Acid or Thioctic Acid) Recalled by...

The Issue: Presence of Particulate Matter: filmy/cloudy particulate observed in vial.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 10, 2019· MAJOR PHARMACEUTICALS

Recalled Item: Losartan Potassium Tablets Recalled by MAJOR PHARMACEUTICALS Due to CGMP...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund